カテゴリー： QYResearch, 世界, 医療/バイオ

世界の完全埋め込み型静脈内投与装置（TIVAD）市場インサイト及び予測（チタン製ポートボディ、プラスチック製ポートボディ）

◆英語タイトル：Global Totally Implantable Intravenous Device (TIVAD) Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX10180）◆商品コード：QY22JLX10180
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：115
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、完全埋め込み型静脈内投与装置（TIVAD）のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に完全埋め込み型静脈内投与装置（TIVAD）の世界市場のxxx％を占める「チタン製ポートボディ」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「がん」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
完全埋め込み型静脈内投与装置（TIVAD）の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの完全埋め込み型静脈内投与装置（TIVAD）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

完全埋め込み型静脈内投与装置（TIVAD）のグローバル主要企業には、C.R. Bard、AngioDynamics、Smiths Medical、Bard Access Systems、B. Braun、Teleflex、Cook Medical、Fresenius Kabi、PFM Medical、Vygon、Districlass、PakuMed、MedComp、Navilyst Medical、Norfolk Medical Products、Suzhou Linhwa Medical Devices、Weigao Holding、Guangdong Baihe Medical Technologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

完全埋め込み型静脈内投与装置（TIVAD）市場は、種類と用途によって区分されます。世界の完全埋め込み型静脈内投与装置（TIVAD）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
チタン製ポートボディ、プラスチック製ポートボディ

【用途別セグメント】
がん、末期腎不全、糖尿病

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 完全埋め込み型静脈内投与装置（TIVAD）製品概要
- 種類別市場（チタン製ポートボディ、プラスチック製ポートボディ）
- 用途別市場（がん、末期腎不全、糖尿病）
- 調査の目的
・エグゼクティブサマリー
- 世界の完全埋め込み型静脈内投与装置（TIVAD）販売量予測2017-2028
- 世界の完全埋め込み型静脈内投与装置（TIVAD）売上予測2017-2028
- 完全埋め込み型静脈内投与装置（TIVAD）の地域別販売量
- 完全埋め込み型静脈内投与装置（TIVAD）の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別完全埋め込み型静脈内投与装置（TIVAD）販売量
- 主要メーカー別完全埋め込み型静脈内投与装置（TIVAD）売上
- 主要メーカー別完全埋め込み型静脈内投与装置（TIVAD）価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（チタン製ポートボディ、プラスチック製ポートボディ）
- 完全埋め込み型静脈内投与装置（TIVAD）の種類別販売量
- 完全埋め込み型静脈内投与装置（TIVAD）の種類別売上
- 完全埋め込み型静脈内投与装置（TIVAD）の種類別価格
・用途別市場規模（がん、末期腎不全、糖尿病）
- 完全埋め込み型静脈内投与装置（TIVAD）の用途別販売量
- 完全埋め込み型静脈内投与装置（TIVAD）の用途別売上
- 完全埋め込み型静脈内投与装置（TIVAD）の用途別価格
・北米市場
- 北米の完全埋め込み型静脈内投与装置（TIVAD）市場規模（種類別、用途別）
- 主要国別の完全埋め込み型静脈内投与装置（TIVAD）市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの完全埋め込み型静脈内投与装置（TIVAD）市場規模（種類別、用途別）
- 主要国別の完全埋め込み型静脈内投与装置（TIVAD）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の完全埋め込み型静脈内投与装置（TIVAD）市場規模（種類別、用途別）
- 主要国別の完全埋め込み型静脈内投与装置（TIVAD）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の完全埋め込み型静脈内投与装置（TIVAD）市場規模（種類別、用途別）
- 主要国別の完全埋め込み型静脈内投与装置（TIVAD）市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの完全埋め込み型静脈内投与装置（TIVAD）市場規模（種類別、用途別）
- 主要国別の完全埋め込み型静脈内投与装置（TIVAD）市場規模（トルコ、サウジアラビア）
・企業情報
C.R. Bard、AngioDynamics、Smiths Medical、Bard Access Systems、B. Braun、Teleflex、Cook Medical、Fresenius Kabi、PFM Medical、Vygon、Districlass、PakuMed、MedComp、Navilyst Medical、Norfolk Medical Products、Suzhou Linhwa Medical Devices、Weigao Holding、Guangdong Baihe Medical Technology
・産業チェーン及び販売チャネル分析
- 完全埋め込み型静脈内投与装置（TIVAD）の産業チェーン分析
- 完全埋め込み型静脈内投与装置（TIVAD）の原材料
- 完全埋め込み型静脈内投与装置（TIVAD）の生産プロセス
- 完全埋め込み型静脈内投与装置（TIVAD）の販売及びマーケティング
- 完全埋め込み型静脈内投与装置（TIVAD）の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 完全埋め込み型静脈内投与装置（TIVAD）の産業動向
- 完全埋め込み型静脈内投与装置（TIVAD）のマーケットドライバー
- 完全埋め込み型静脈内投与装置（TIVAD）の課題
- 完全埋め込み型静脈内投与装置（TIVAD）の阻害要因
・主な調査結果

The totally implantable venous access deviceis a blood vessel or thoracoabdominal access device that is completely implanted in the body, which can reduce the pain and risk of repeated vein, artery, thoracoabdominal puncture.
Market Analysis and Insights: Global Totally Implantable Intravenous Device (TIVAD) Market
Due to the COVID-19 pandemic, the global Totally Implantable Intravenous Device (TIVAD) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Titanium Port Body accounting for % of the Totally Implantable Intravenous Device (TIVAD) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cancer segment is altered to an % CAGR throughout this forecast period.
China Totally Implantable Intravenous Device (TIVAD) market size is valued at US$ million in 2021, while the US and Europe Totally Implantable Intravenous Device (TIVAD) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Totally Implantable Intravenous Device (TIVAD) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Totally Implantable Intravenous Device (TIVAD) include C.R. Bard, AngioDynamics, Smiths Medical, Bard Access Systems, B. Braun, Teleflex, Cook Medical, Fresenius Kabi and PFM Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Totally Implantable Intravenous Device (TIVAD) Scope and Segment
Totally Implantable Intravenous Device (TIVAD) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Totally Implantable Intravenous Device (TIVAD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Titanium Port Body
Plastic Port Body
Segment by Application
Cancer
End-Stage Renal Disease
Diabetes
By Company
C.R. Bard
AngioDynamics
Smiths Medical
Bard Access Systems
B. Braun
Teleflex
Cook Medical
Fresenius Kabi
PFM Medical
Vygon
Districlass
PakuMed
MedComp
Navilyst Medical
Norfolk Medical Products
Suzhou Linhwa Medical Devices
Weigao Holding
Guangdong Baihe Medical Technology
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Totally Implantable Intravenous Device (TIVAD) Product Introduction
1.2 Market by Type
1.2.1 Global Totally Implantable Intravenous Device (TIVAD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Titanium Port Body
1.2.3 Plastic Port Body
1.3 Market by Application
1.3.1 Global Totally Implantable Intravenous Device (TIVAD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 End-Stage Renal Disease
1.3.4 Diabetes
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Totally Implantable Intravenous Device (TIVAD) Sales Estimates and Forecasts 2017-2028
2.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue Estimates and Forecasts 2017-2028
2.3 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Totally Implantable Intravenous Device (TIVAD) Sales by Region
2.4.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Region (2017-2022)
2.4.2 Global Sales Totally Implantable Intravenous Device (TIVAD) by Region (2023-2028)
2.5 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region
2.5.1 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region (2017-2022)
2.5.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Manufacturers
3.1.1 Global Top Totally Implantable Intravenous Device (TIVAD) Manufacturers by Sales (2017-2022)
3.1.2 Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Totally Implantable Intravenous Device (TIVAD) in 2021
3.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Manufacturers
3.2.1 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Manufacturers (2017-2022)
3.2.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Totally Implantable Intravenous Device (TIVAD) Revenue in 2021
3.3 Global Totally Implantable Intravenous Device (TIVAD) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Totally Implantable Intravenous Device (TIVAD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Totally Implantable Intravenous Device (TIVAD) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Type
4.1.1 Global Totally Implantable Intravenous Device (TIVAD) Historical Sales by Type (2017-2022)
4.1.2 Global Totally Implantable Intravenous Device (TIVAD) Forecasted Sales by Type (2023-2028)
4.1.3 Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Type (2017-2028)
4.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Type
4.2.1 Global Totally Implantable Intravenous Device (TIVAD) Historical Revenue by Type (2017-2022)
4.2.2 Global Totally Implantable Intravenous Device (TIVAD) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Type (2017-2028)
4.3 Global Totally Implantable Intravenous Device (TIVAD) Price by Type
4.3.1 Global Totally Implantable Intravenous Device (TIVAD) Price by Type (2017-2022)
4.3.2 Global Totally Implantable Intravenous Device (TIVAD) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Totally Implantable Intravenous Device (TIVAD) Sales by Application
5.1.1 Global Totally Implantable Intravenous Device (TIVAD) Historical Sales by Application (2017-2022)
5.1.2 Global Totally Implantable Intravenous Device (TIVAD) Forecasted Sales by Application (2023-2028)
5.1.3 Global Totally Implantable Intravenous Device (TIVAD) Sales Market Share by Application (2017-2028)
5.2 Global Totally Implantable Intravenous Device (TIVAD) Revenue by Application
5.2.1 Global Totally Implantable Intravenous Device (TIVAD) Historical Revenue by Application (2017-2022)
5.2.2 Global Totally Implantable Intravenous Device (TIVAD) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Totally Implantable Intravenous Device (TIVAD) Revenue Market Share by Application (2017-2028)
5.3 Global Totally Implantable Intravenous Device (TIVAD) Price by Application
5.3.1 Global Totally Implantable Intravenous Device (TIVAD) Price by Application (2017-2022)
5.3.2 Global Totally Implantable Intravenous Device (TIVAD) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Totally Implantable Intravenous Device (TIVAD) Market Size by Type
6.1.1 North America Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2028)
6.1.2 North America Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2028)
6.2 North America Totally Implantable Intravenous Device (TIVAD) Market Size by Application
6.2.1 North America Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2028)
6.2.2 North America Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2028)
6.3 North America Totally Implantable Intravenous Device (TIVAD) Market Size by Country
6.3.1 North America Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2028)
6.3.2 North America Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Totally Implantable Intravenous Device (TIVAD) Market Size by Type
7.1.1 Europe Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2028)
7.1.2 Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2028)
7.2 Europe Totally Implantable Intravenous Device (TIVAD) Market Size by Application
7.2.1 Europe Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2028)
7.2.2 Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2028)
7.3 Europe Totally Implantable Intravenous Device (TIVAD) Market Size by Country
7.3.1 Europe Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2028)
7.3.2 Europe Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Market Size by Type
8.1.1 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2028)
8.1.2 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2028)
8.2 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Market Size by Application
8.2.1 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2028)
8.2.2 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2028)
8.3 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Market Size by Region
8.3.1 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Sales by Region (2017-2028)
8.3.2 Asia Pacific Totally Implantable Intravenous Device (TIVAD) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Totally Implantable Intravenous Device (TIVAD) Market Size by Type
9.1.1 Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2028)
9.1.2 Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2028)
9.2 Latin America Totally Implantable Intravenous Device (TIVAD) Market Size by Application
9.2.1 Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2028)
9.2.2 Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2028)
9.3 Latin America Totally Implantable Intravenous Device (TIVAD) Market Size by Country
9.3.1 Latin America Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2028)
9.3.2 Latin America Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Market Size by Type
10.1.1 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Type (2017-2028)
10.2 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Market Size by Application
10.2.1 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Application (2017-2028)
10.3 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Market Size by Country
10.3.1 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Totally Implantable Intravenous Device (TIVAD) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 C.R. Bard
11.1.1 C.R. Bard Corporation Information
11.1.2 C.R. Bard Overview
11.1.3 C.R. Bard Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 C.R. Bard Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 C.R. Bard Recent Developments
11.2 AngioDynamics
11.2.1 AngioDynamics Corporation Information
11.2.2 AngioDynamics Overview
11.2.3 AngioDynamics Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AngioDynamics Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AngioDynamics Recent Developments
11.3 Smiths Medical
11.3.1 Smiths Medical Corporation Information
11.3.2 Smiths Medical Overview
11.3.3 Smiths Medical Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Smiths Medical Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Smiths Medical Recent Developments
11.4 Bard Access Systems
11.4.1 Bard Access Systems Corporation Information
11.4.2 Bard Access Systems Overview
11.4.3 Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bard Access Systems Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bard Access Systems Recent Developments
11.5 B. Braun
11.5.1 B. Braun Corporation Information
11.5.2 B. Braun Overview
11.5.3 B. Braun Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 B. Braun Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B. Braun Recent Developments
11.6 Teleflex
11.6.1 Teleflex Corporation Information
11.6.2 Teleflex Overview
11.6.3 Teleflex Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teleflex Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teleflex Recent Developments
11.7 Cook Medical
11.7.1 Cook Medical Corporation Information
11.7.2 Cook Medical Overview
11.7.3 Cook Medical Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cook Medical Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cook Medical Recent Developments
11.8 Fresenius Kabi
11.8.1 Fresenius Kabi Corporation Information
11.8.2 Fresenius Kabi Overview
11.8.3 Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Fresenius Kabi Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Fresenius Kabi Recent Developments
11.9 PFM Medical
11.9.1 PFM Medical Corporation Information
11.9.2 PFM Medical Overview
11.9.3 PFM Medical Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 PFM Medical Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PFM Medical Recent Developments
11.10 Vygon
11.10.1 Vygon Corporation Information
11.10.2 Vygon Overview
11.10.3 Vygon Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Vygon Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vygon Recent Developments
11.11 Districlass
11.11.1 Districlass Corporation Information
11.11.2 Districlass Overview
11.11.3 Districlass Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Districlass Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Districlass Recent Developments
11.12 PakuMed
11.12.1 PakuMed Corporation Information
11.12.2 PakuMed Overview
11.12.3 PakuMed Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 PakuMed Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 PakuMed Recent Developments
11.13 MedComp
11.13.1 MedComp Corporation Information
11.13.2 MedComp Overview
11.13.3 MedComp Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 MedComp Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 MedComp Recent Developments
11.14 Navilyst Medical
11.14.1 Navilyst Medical Corporation Information
11.14.2 Navilyst Medical Overview
11.14.3 Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Navilyst Medical Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Navilyst Medical Recent Developments
11.15 Norfolk Medical Products
11.15.1 Norfolk Medical Products Corporation Information
11.15.2 Norfolk Medical Products Overview
11.15.3 Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Norfolk Medical Products Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Norfolk Medical Products Recent Developments
11.16 Suzhou Linhwa Medical Devices
11.16.1 Suzhou Linhwa Medical Devices Corporation Information
11.16.2 Suzhou Linhwa Medical Devices Overview
11.16.3 Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Suzhou Linhwa Medical Devices Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Suzhou Linhwa Medical Devices Recent Developments
11.17 Weigao Holding
11.17.1 Weigao Holding Corporation Information
11.17.2 Weigao Holding Overview
11.17.3 Weigao Holding Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Weigao Holding Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Weigao Holding Recent Developments
11.18 Guangdong Baihe Medical Technology
11.18.1 Guangdong Baihe Medical Technology Corporation Information
11.18.2 Guangdong Baihe Medical Technology Overview
11.18.3 Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Guangdong Baihe Medical Technology Totally Implantable Intravenous Device (TIVAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Guangdong Baihe Medical Technology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Totally Implantable Intravenous Device (TIVAD) Industry Chain Analysis
12.2 Totally Implantable Intravenous Device (TIVAD) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Totally Implantable Intravenous Device (TIVAD) Production Mode & Process
12.4 Totally Implantable Intravenous Device (TIVAD) Sales and Marketing
12.4.1 Totally Implantable Intravenous Device (TIVAD) Sales Channels
12.4.2 Totally Implantable Intravenous Device (TIVAD) Distributors
12.5 Totally Implantable Intravenous Device (TIVAD) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Totally Implantable Intravenous Device (TIVAD) Industry Trends
13.2 Totally Implantable Intravenous Device (TIVAD) Market Drivers
13.3 Totally Implantable Intravenous Device (TIVAD) Market Challenges
13.4 Totally Implantable Intravenous Device (TIVAD) Market Restraints
14 Key Findings in The Global Totally Implantable Intravenous Device (TIVAD) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の完全埋め込み型静脈内投与装置（TIVAD）市場インサイト及び予測（チタン製ポートボディ、プラスチック製ポートボディ）(Global Totally Implantable Intravenous Device (TIVAD) Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 植込み型医療機器用ワイヤレス電源のグローバル市場展望 2023年-2029年：高周波装置、磁気誘導装置、磁気共鳴充電装置、その他
  • 世界の静脈内レーザー治療市場インサイト及び予測（静脈内レーザーシステム、静脈内レーザーファイバー）
  • 世界の植込み型ループモニター市場インサイト及び予測（スマートフォン対応、スマートフォン非互換）
  • 世界の女性用外部尿収集装置（EUCD）市場インサイト及び予測（使い捨て装置、再利用可能装置）
  • 世界の骨伝導補聴器・ヘッドホン市場2022年：骨伝導埋め込み型補聴器、骨伝導ヘッドホン